NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

神經刺激:技術和全球市場

Neurostimulation: Technologies and Global Markets

出版商 BCC Research 商品編碼 1005705
出版日期 內容資訊 英文 121 Pages
訂單完成後即時交付
價格
神經刺激:技術和全球市場 Neurostimulation: Technologies and Global Markets
出版日期: 2021年05月13日內容資訊: 英文 121 Pages
簡介

全球神經刺激器市場預計將從 2021 年的 71 億美元增長到 2026 年的 98 億美元。

此外,預測期間(2021-2026 年)的複合年增長率預計為 6.9%。

本報告分析了全球神經刺激技術/設備市場,概述了技術和應用領域、市場基本結構和主要促進/抑制因素,以及整體市場規模趨勢展望(2020)~2026 )、技術類型/產品的詳細趨勢、技術發展和資本交易的近期趨勢、主要公司簡介和業務發展狀況等將被匯總和交付。

目錄

第 1 章介紹

第 2 章摘要亮點

第 3 章市場與技術背景

  • 神經刺激:總結
  • 神經刺激技術的種類
  • 脊髓刺激
  • 深部腦刺激
  • □神經刺激(SNS)
  • 迷走神經刺激
  • 舌下神經刺激
  • 經皮電神經刺激
  • 經顱磁刺激 (TMS)
  • 其他
  • 神經刺激技術/器械治療應用
  • 慢性疼痛管理
  • 神經紊亂
  • 尿失禁/大便失禁
  • 阻塞性睡眠呼吸暫停
  • 慢性偏頭痛/頭痛
  • 心血管疾病
  • 胃腸道疾病
  • 肥胖
  • 精神疾病
  • 技術開發
  • MRI 兼容性
  • 可充電/不可充電設備

第 4 章按技術/設備類型劃分的市場分類

  • 全球神經刺激器市場:按類型
  • 脊髓刺激 (SCS) 裝置
  • 經皮神經電刺激 (TENS) 裝置
  • 深部腦刺激 (DBS) 設備
  • □神經刺激(SNS)裝置
  • 迷走神經刺激 (VNS) 裝置
  • 舌下神經刺激 (HGNS) 裝置
  • 市場規模及其預測
  • 經顱磁刺激 (TMS) 設備
  • 其他類型的神經刺激器

第 5 章按地區劃分的市場分類

  • 全球神經刺激器市場:按地區
  • 北美
  • 歐洲
  • 亞洲
  • 其他領域

第 6 章按用途劃分的市場分類

  • 全球神經刺激器市場:按治療應用
  • 慢性疼痛
  • 尿失禁/大便失禁
  • 帕金森病
  • 癲癇
  • 阻塞性睡眠呼吸暫停 (OSA)
  • 特發性震顫
  • 重度憂鬱症 (MDD)/臨床憂鬱症
  • 強迫症 (OCD)
  • 其他

第 7 章主要推出的產品/技術

  • 最近的治療改進和新的適應症
  • 脊髓刺激
  • 深部腦刺激
  • □神經刺激(SNS)
  • 迷走神經動作
  • 舌下神經刺激
  • 經皮電神經刺激
  • 經顱磁刺激
  • 其他類型的刺激
  • 新適應症和神經刺激療法

第 8 章競爭形勢

  • 按公司劃分的市場份額:按產品細分
  • 脊髓刺激器
  • 深部腦刺激器
  • □神經刺激器
  • 迷走神經刺激器
  • 舌下神經刺激器
  • 經顱磁刺激器
  • 經皮神經電刺激器
  • 行業近期趨勢

第 9 章市場動態

  • 市場趨勢
  • 增長因素
  • 市場限制

第 10 章新型冠狀病毒感染 (COVID-19) 的影響

第 11 章公司簡介

  • ABBOTT LABORATORIES
  • ALEVA NEUROTHERAPEUTICS SA
  • AVERY BIOMEDICAL DEVICES INC.
  • AXONICS MODULATION TECHNOLOGIES INC.
  • BIOINDUCTION LTD.
  • BIONESS INC.
  • BIOWAVE CORP.
  • BOSTON SCIENTIFIC CORP.
  • BRAINSWAY LTD.
  • COCHLEAR AMERICAS
  • CVRX INC.
  • ELECTROCORE INC.
  • INSPIRE MEDICAL SYSTEMS INC.
  • INTEGER HOLDINGS CORP.
  • LABORIE INC.
  • LIVANOVA PLC
  • MAG & MORE GMBH
  • MAGSTIM INC.
  • MEDTRONIC PLC
  • NALU MEDICAL INC.
  • NEUROMED CONSULTING INC.
  • NEUROMETRIX INC.
  • NEURONETICS INC.
  • NEUROPACE INC.
  • NEUROSIGMA INC.
  • NEUROVALENS LTD.
  • NEVRO CORP.
  • NEXSTIM PLC
  • NYXOAH SA
  • RESPICARDIA INC.
  • SOTERIX MEDICAL INC.
  • STIMWAVE LLC
  • SYNAPSE BIOMEDICAL INC.
  • TONICA ELEKTRONIK A/S
  • XAVANT TECHNOLOGY(PTY)LTD.

第 12 章附錄:縮略語

目錄
Product Code: PHM149B

Highlights:

The global neurostimulation devices market should reach $9.8 billion by 2026 from $7.1 billion in 2021 at a compound annual growth rate (CAGR) of 6.9% for the forecast period of 2021 to 2026.

The spinal cord stimulation (SCS) devices segment of the global neurostimulation devices market is expected to grow from $2.3 billion in 2021 to $2.7 billion in 2026 at a CAGR of 3.4% for the forecast period of 2021 to 2026.

The deep brain stimulation (DBS) devices segment of the global neurostimulation devices market is expected to grow from $1.2 billion in 2021 to $2.1 billion in 2026 at a CAGR of 12.8% for the forecast period of 2021 to 2026.

Report Scope:

This report aims to provide a comprehensive study of the global market for neurostimulation technologies/devices. It provides a detailed description of the different types of neurostimulation technologies/devices (invasive and noninvasive) and their current and historical market revenues.

Neurostimulation technologies/devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, transcranial magnetic stimulation and others.

This report also covers a detailed study of therapeutic applications of neurostimulation technologies/devices including chronic pain, Parkinson's disease, epilepsy, urinary and fecal incontinence, obstructive sleep apnea, essential tremor, obsessive compulsive disorder, major depressive disorder/clinical depression and others. An in-depth analysis of the global market for neurostimulation technologies/devices includes historical data and market projection on sales by, device type, therapeutic applications and region.

For in-depth understanding of the market, profiles of market participants, key marketed devices, competitive landscape, key competitors, and their respective market shares have been provided. This report also discusses driving and restraining factors of the global neurostimulation technology/devices market.

Report Includes:

  • 21 data tables and 20 additional tables
  • An overview of the global markets and technologies for neurostimulation
  • Estimation of the market size and analyses of market trends, with data from 2020, estimates for 2021 and projection of CAGR through 2026
  • Description of Dorsal Root Ganglion (DRG) neurostimulator system and discussion on approved indications of stimulation therapy for various diseases
  • Information on recent therapy improvements and new indications for use, and discussion on alternatives to traditional stimulation therapies
  • Coverage of ongoing scientific discoveries and technological advances in neurostimulation technologies and insights into marketed and pipeline (R&D) products, product recalls and reimbursement policies
  • Market share analysis of neurostimulation devices by application, type and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges and opportunities affecting market growth
  • Details about symptoms, progression and epidemiology of COVID-19 and discussion on impact of COVID-19 pandemic on medical industry as well as on neurostimulation market
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Comprehensive company profiles of major players of the industry, including Abbott Laboratories, Boston Scientific, Medtronic PLC, NeuroMetrix, NeuroSigma and Soterix Medical Inc.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Scope of This Report
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Introduction to Neurostimulation
  • Types of Neurostimulation Technologies
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation
  • Hypoglossal Nerve Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation (TMS)
  • Others
  • Therapeutic Applications for Neurostimulation Technologies/Devices
  • Chronic Pain Management
  • Neurological Disorders
  • Urinary and Fecal Incontinence
  • Obstructive Sleep Apnea
  • Chronic Migraine and Headache
  • Cardiovascular Diseases
  • Gastrointestinal Disorders
  • Obesity
  • Psychiatric Disorders
  • Technology Developments
  • MRI Compatibility
  • Rechargeable and Non-rechargeable Devices

Chapter 4 Market Breakdown by Technology/Device Type

  • Global Market for Neurostimulation Devices by Type
  • Spinal Cord Stimulation (SCS) Devices
  • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • Deep Brain Stimulation (DBS) Devices
  • Sacral Nerve Stimulation (SNS) Devices
  • Vagus Nerve Stimulation (VNS) Devices
  • Hypoglossal Nerve Stimulation (HGNS) Devices
  • Market Size and Forecast
  • Transcranial Magnetic Stimulation (TMS) Devices
  • Other Types of Neurostimulation Devices

Chapter 5 Market Breakdown by Region

  • Global Markets for Neurostimulation Devices by Region
  • North America
  • Europe
  • Asia
  • RoW

Chapter 6 Market Breakdown by Application

  • Global Market for Neurostimulation Devices by Therapeutic Application
  • Chronic Pain
  • Urinary and Fecal Incontinence
  • Parkinson's Disease
  • Epilepsy
  • Obstructive Sleep Apnea (OSA)
  • Essential Tremor
  • Major Depressive Disorder (MDD)/Clinical Depression
  • Obsessive Compulsive Disorder (OCD)
  • Others

Chapter 7 Key Marketed Products and Technologies

  • Recent Therapeutic Improvements and New Indications
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation
  • Hypoglossal Nerve Stimulation
  • Transcutaneous Electrical Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Other Types of Stimulation
  • New Indications and Neurostimulation Therapies

Chapter 8 Competitive Landscape

  • Company Market Shares by Product Segment
  • Spinal Cord Stimulation Devices
  • Deep Brain Stimulation Devices
  • Sacral Nerve Stimulation Devices
  • Vagus Nerve Stimulation Devices
  • Hypoglossal Nerve Stimulation Devices
  • Transcranial Magnetic Stimulation Devices
  • Transcutaneous Electrical Nerve Stimulation Devices
  • Recent Industry Activities

Chapter 9 Market Dynamics

  • Market Trends
  • Growth Drivers
  • Market Restraints

Chapter 10 Impact of COVID-19

Chapter 11 Company Profiles

  • ABBOTT LABORATORIES
  • ALEVA NEUROTHERAPEUTICS SA
  • AVERY BIOMEDICAL DEVICES INC.
  • AXONICS MODULATION TECHNOLOGIES INC.
  • BIOINDUCTION LTD.
  • BIONESS INC.
  • BIOWAVE CORP.
  • BOSTON SCIENTIFIC CORP.
  • BRAINSWAY LTD.
  • COCHLEAR AMERICAS
  • CVRX INC.
  • ELECTROCORE INC.
  • INSPIRE MEDICAL SYSTEMS INC.
  • INTEGER HOLDINGS CORP.
  • LABORIE INC.
  • LIVANOVA PLC
  • MAG & MORE GMBH
  • MAGSTIM INC.
  • MEDTRONIC PLC
  • NALU MEDICAL INC.
  • NEUROMED CONSULTING INC.
  • NEUROMETRIX INC.
  • NEURONETICS INC.
  • NEUROPACE INC.
  • NEUROSIGMA INC.
  • NEUROVALENS LTD.
  • NEVRO CORP.
  • NEXSTIM PLC
  • NYXOAH SA
  • RESPICARDIA INC.
  • SOTERIX MEDICAL INC.
  • STIMWAVE LLC
  • SYNAPSE BIOMEDICAL INC.
  • TONICA ELEKTRONIK A/S
  • XAVANT TECHNOLOGY (PTY) LTD.

Chapter 12 Appendix: Acronyms

List of Tables

  • Summary Table : Global Market for Neurostimulation Devices, by Type, Through 2026
  • Table 1 : Prevalence of Chronic Pain and High Impact Chronic Pain Among U.S. Adults, by Sociodemographic Characteristics, 2016
  • Table 2 : U.S. Distribution Share of Location of Chronic Pin in the Body
  • Table 3 : Prevalence of Adult Overweight and Obese Population in Select Countries, 2014-2019
  • Table 4 : Global Market for Neurostimulation Devices, by Type, Through 2026
  • Table 5 : Global Market for Spinal Cord Stimulation (SCS) Devices, by Region, Through 2026
  • Table 6 : Global Market for Transcutaneous Electrical Nerve Stimulation (TENS) Devices, by Region, Through 2026
  • Table 7 : Global Market for Deep Brain Stimulation (DBS) Devices, by Region, Through 2026
  • Table 8 : Global Market for Sacral Nerve Stimulation (SNS) Devices, by Region, Through 2026
  • Table 9 : Global Market for Vagus Nerve Stimulation (VNS) Devices, by Region, Through 2026
  • Table 10 : Global Market for Hypoglossal Nerve Stimulation (HGNS) Devices, by Region, Through 2026
  • Table 11 : Global Market for Transcranial Magnetic Stimulation (TMS) Devices, by Region, Through 2026
  • Table 12 : Global Market for Other Types of Neurostimulation Devices, by Region, Through 2026
  • Table 13 : Global Market for Neurostimulation Devices, by Region, Through 2026
  • Table 14 : Global Market for Neurostimulation Devices, by Therapeutic Application, Through 2026
  • Table 15 : Implantable Neurostimulation Devices Approved, January 2018-January 2021
  • Table 16 : Currently Available Spinal Cord Stimulation Systems
  • Table 17 : Currently Available Deep Brain Stimulation Systems
  • Table 18 : Currently Available Sacral Nerve Stimulation Systems
  • Table 19 : Currently Available Vagus Nerve Stimulation Systems
  • Table 20 : U.S. FDA-Approved Transcutaneous Electrical Nerve Stimulation Systems for Pain Relief Treatment, January 2015-March 31, 2021
  • Table 21 : U.S. FDA-Approved Transcutaneous Electrical Nerve Stimulation Systems for Treatment of Migraine Pain Relief, January 2015-March 31, 2021
  • Table 22 : Currently Available Phrenic Nerve Stimulation Systems for Respiratory Insufficiency
  • Table 23 : Currently Available Hypoglossal Nerve Stimulation Systems for Respiratory Insufficiency
  • Table 24 : Currently Available Peripheral Nerve Stimulation Systems
  • Table 25 : Currently Available Transcranial Magnetic Stimulating Systems
  • Table 26 : Currently Available Gastric Electrical Stimulation System
  • Table 27 : Neurostimulation Stimulation Product Pipeline Highlights
  • Table 28 : Active Clinical Trials on Spinal Cord Stimulation Technology
  • Table 29 : Active Clinical Trials on DBS Technology
  • Table 30 : Active Clinical Trials on VNS Technology
  • Table 31 : Active Clinical Trials on Sacral Nerve Stimulation Technology
  • Table 32 : Active Clinical Trials on Peripheral Nerve Stimulation Technology
  • Table 33 : Active Clinical Trials on Hypoglossal Nerve Stimulation Technology
  • Table 34 : Global Market Shares of Leading Companies in Spinal Cord Stimulation Devices, 2020
  • Table 35 : Global Market Shares of Leading Companies in Deep Brain Stimulation Devices, 2020
  • Table 36 : Global Market Shares of Leading Companies in Sacral Nerve Stimulation Devices, 2020
  • Table 37 : Global Market Shares of Leading Companies in Vagus Nerve Stimulation Devices, 2020
  • Table 38 : Global Market Shares of Leading Companies in Hypoglossal Nerve Stimulation Devices, 2020
  • Table 39 : Global Market Shares of Leading Companies in Transcranial Magnetic Stimulation Devices, 2020
  • Table 40 : Acronyms Used in This Report

List of Figures

  • Summary Figure : Global Market for Neurostimulation Devices, by Type, 2020-2026
  • Figure 1 : Global Market Shares of Neurostimulation Devices, by Type, 2020
  • Figure 2 : Global Market Shares of Spinal Cord Stimulation Devices, by Region, 2020
  • Figure 3 : Global Market Shares of Transcutaneous Electrical Nerve Stimulation Devices, by Region, 2020
  • Figure 4 : Global Market Shares of Deep Brain Stimulation Devices, by Region, 2020
  • Figure 5 : Global Market Shares of Sacral Nerve Stimulation Devices, by Region, 2020
  • Figure 6 : Global Market Shares of Vagus Nerve Stimulation Devices, by Region, 2020
  • Figure 7 : Global Market Shares of Hypoglossal Nerve Stimulation Devices, by Region, 2020
  • Figure 8 : Global Market Shares of Transcranial Magnetic Stimulation Devices, by Region, 2020
  • Figure 9 : Global Market Shares of Other Types of Neurostimulation Devices, by Region, 2020
  • Figure 10 : Global Market Shares of Other Neurostimulation Devices, by Region, 2020
  • Figure 11 : Global Market Shares of Neurostimulation Devices, by Therapeutic Application, 2020
  • Figure 12 : Global Market Shares of Leading Companies in Spinal Cord Stimulation Devices, 2020
  • Figure 13 : Global Market Shares of Leading Companies in Deep Brain Stimulation Devices, 2020
  • Figure 14 : Global Market Shares of Leading Companies in Sacral Nerve Stimulation Devices, 2020
  • Figure 15 : Global Market Shares of Leading Companies in Vagus Nerve Stimulation Devices, 2020
  • Figure 16 : Global Market Shares of Leading Companies in Hypoglossal Nerve Stimulation Devices, 2020
  • Figure 17 : Global Market Shares of Leading Companies in Transcranial Magnetic Stimulation Devices, 2020